Search filters

List of works by Chung-Han Lee

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

scientific article published on 31 December 2020

A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma.

scientific article published on 04 December 2013

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs.

scientific article published on 07 August 2015

Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma.

scientific article published on 23 February 2016

Combination therapy for advanced and metastatic kidney cancer

scientific article published on 01 February 2019

Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.

scientific article published on 25 October 2007

From molecular understanding to clinical advances

scientific article published on 24 December 2013

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

scientific article published on 14 July 2021

Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma.

scientific article

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

scientific article published on 02 July 2020

mTOR pathway as a target in tissue hypertrophy.

scientific article published on January 2007

Paulina is supported by:

About Paulina

Help